2019 International Congress Archives - Page 130 of 217

Daily variability of non-motor symptoms as a reflection of circadian dysregulation in Parkinson’s disease

O. Alenikova, S. Likhchev, A. Buniak, M. Liashkovich (Minsk, Belarus)
Dancing larynx syndrome associated with trigeminal neuralgia secondary to multiple sclerosis

D. Shpiner, M. Ortega, H. Moore (Miami, FL, USA)
Data quality, acceptability and reliability of the Movement Disorders Society – Non Motor Rating Scale (MDS-NMS)

C. Rodriguez-Blazquez, A. Schrag, D. Weintraub, A. Rizos, KR. Chaudhuri, P. Martinez-Martin (Madrid, Spain)
Day Hospitals Reinvented : the future of Parkinson’s care

J. Adenwalla, S. Jones, M. Oliver, N. Noushad, B. Mohamed, C. Thomas, T. Williams, S. Mahon (Cardiff, United Kingdom)
Daytime Sleepiness Effects on Motor Symptoms in De Novo Parkinson’s Disease

E. Bayram, R. Yilmaz, K. Longardner, M. Akbostanci, I. Litvan (La Jolla, CA, USA)
Daytime sleepiness in Parkinson’s disease: an indicator of impaired activities of daily living

T. Canento, J. Tan, B. Cruse, C. Wools, M. Ghaly, M. Beckley, F. Leen, AH. Evans (Melbourne, Australia)
DBS for Parkinson-Dementia syndrome: Stimulation of both Globus Pallidus internus & the Nucleus Basalis of Meynert using the same electrode lead

C. Nombela, A. Lozano, C. Villanueva-Iza, J. Barcia (Madrid, Spain)
DBS for PD in Albania

I. Zekja, R. Alimehmeti, F. Dashi, S. Grabova, M. Petrela, M. Rralacolli, J. Kruja (Tirana, Albania)
DBS in Parkinson’s disease: Experience from Egypt

A. Mansour, Z. Fayed (Cairo, Egypt)
DBS Programming In Tremor And Akinetic-Rigid Predominant Parkinson’s Disease

Z. Guduru, D. Ginjupally, T. Ali, N. El Seblani, J. Quintero, C. van Horne (Lexington, KY, USA)
DCM extract of Scutellaria Pinnatifida modulate alpha-synuclein fibrillation and protects dopaminergic SH-SY5Y cells against rotenone

S. Parsafar, D. Morshedi, M. Mohammadi (Tehran, Islamic Republic of Iran)
Deceleration capacity of heart rate: is cardiac vagal modulation impaired in idiopathic Parkinson’s disease?

C. Carricarte Naranjo, C. Marras, N. Visanji, D. Cornforth, L. Sanchez-Rodriguez, B. Schüle, S. Goldman, M. Estevez, P. Stein, A. Lang, H. Jelinek, A. Machado (La Habana, Cuba)
Deciphering Corticobasal Syndrome: are clinical features and FDG-PET imaging capable of predicting amiloyd status?

J. Parmera, A. Coutinho, A. Neto, M. Aranha, C. Ono, C. Buchpiguel, R. Nitrini, E. Barbosa, S. Brucki (São Paulo, Brazil)
Deciphering the role of posttranslational modifications on α-synuclein aggregation and toxicity

T. Outeiro (Goettingen, Germany)
Decline in Neural Connectivity in Olfactory Spatial Attention: A Comparative Study in the Progression of Parkinson’s Disease

H. Chatterjee, G. Elumalai, N. Osakwe, N. Sewram (Georgetown, Guyana)
Decreased baroreflex sensitivity in Parkinson’s disease is associated with orthostatic hypotension

P. Turcani, P. Valkovic, P. Siarnik, S. Sutovsky (Bratislava, Slovakia)
Decreased Cannabinoid Type 1 Receptor Density in Parkinson’s Disease: A [18F]FMPEP-d2 PET Study

A. Brück, H. Al-Abdulrasul, J. Tuisku, R. Ajalin, J. Hirvonen, J. Rinne (Turku, Finland)
Decreased serum alpha-synuclein in patients with Restless Legs Syndrome and association with SNCA-Rep1 polymorphism

YC. Wu, XY. Zhu, TT. Wu, T. Liu, HM. Wang, YJ. Chen, X. Li, XX. Cui (Shanghai, China)
Deep Brain Stimulation (DBS) clinical impedance measurements of the Medtronic Clinician 8840 versus the Samsung Galaxy Tab S2 tablet interface

D. Caputo, S. Danish, E. Hargreaves (New Brunswick, NJ, USA)
Deep Brain Stimulation (DBS) in Pantothenate Kinase-Associated Neurodegeneration (PKAN): An Experience in a Thai Patient

P. Termsarasab, P. Boonkongchuen, T. Pulkes, O. Trachoo, A. Boongird (Bangkok, Thailand)
Deep Brain Stimulation as a Rescue When Duodenal Levodopa Infusion Fails: Report of 2 Cases

N. Nathoo, T. Sankar, O. Suchowersky, F. Ba (Edmonton, AB, Canada)
Deep Brain Stimulation as second line advanced treatment for PD after LCIG

A. Faust-Socher, F. Abu Ahmad, N. Giladi, A. Hilel, Y. Shapira, D. Klepikov, A. Ezra, L. Raif, T. Gurevich (Tel Aviv, Israel)
Deep Brain Stimulation for atypical tremors secondary to Neuroferritinopathy: Single center experience

S. Chandra, J. Randhawa, M. Schiess (Houston, TX, USA)
Deep Brain Stimulation for Parkinson’s disease: the Paradox of More Technological Approaches

D. Soh, T. Ten Brinke, A. Lozano, A. Fasano (Toronto, ON, Canada)
Deep brain stimulation in children: analysis of indication, outcome and complications

DR. Maiti (Cleveland, OH, USA)
Deep Brain Stimulation in Early-Stage Parkinson’s Disease Provides Long-Term Rest Tremor Benefit Through Five Years

M. Hacker, M. Turchan, T. Davis, F. Phibbs, P. Hedera, P. Konrad, D. Charles (Nashville, TN, USA)
Deep Brain Stimulation in Parkinson’s Disease: Experience of the Neurology Department of Marrakesh

Z. Chourafa, M. Chraa, N. Louhab, N. Kissani (Marrakesh, Morocco)
Deep brain stimulation in patients with chronic anti-coagulation treatment: a series of 35 patients

J. Krauss, L. Cassini Ascencao, J. Runge, A. Saryyeva (Hannover, Germany)
Deep brain stimulation of Caudal Zona incerta: Case series

DR. Ginjupally, Z. Guduru, T. Hines Iii, T. Ali, G. Quintero, C. van Horne (Lexington, KY, USA)
Deep Brain Stimulation of Subthalamic Nucleus (DBS-STN) in Parkinson Disease (PD): Acute Clinical Effects in Hypothalamic control

D. Dos Santos, E. Barbosa, R. Cury (São Paulo, Brazil)
Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus for apathy in PD patients

X. Zhang, A. Xie (Qingdao, China)
Deep Brain Stimulation of VIM Thalamic Nucleus for Tremor Control

J. Santos (Rio de Janeiro, Brazil)
Deep Brain Stimulation Wash-in/out Periods Quantified using a Palm-Worn Device to Monitor Rigidity

T. Perera, WL. Lee, M. Jones, J. Tan, E. Proud, A. Begg, N. Sinclair, R. Peppard, H. Mcdermott (East Melbourne, Australia)
Deep brain stimulation-guided optogenetic rescue of parkinsonian symptoms

B. Degos, M. Vandecasteele, S. Valverde, C. Piette, G. Gangarossa, W. Derousseaux, A. Aristieta Arbelaiz, J. Touboul, L. Venance (Paris, France)
Deep mitochondrial sequencing in Parkinson’s disease reveals possible genetic modifiers of reduced penetrance in Parkin/PINK1 mutation carriers

J. Trinh, A. Hicks, K. Wasner, M. Farrer, F. Hentati, P. Bauer, S. Imhoff, K. Kandaswamy, N. Ouzren, M. Werber, A. Rolfs, V. Kostic, A. Lang, P. Pramstaller, P. Seibler, K. Lohmann, A. Gruenewald, C. Klein (Luebeck, Germany)
Deep phenotyping adult onset isolated cervical dystonia; the importance of symptomatic anxiety and depression.

I. Ndukwe, J. Dover, P. Lynch, F. O'Keeffe, S. O'Riordan, M. Hutchinson (Dublin, Ireland)
Defective human motion perception in cervical dystonia correlates with coexisting tremor

D. Martino, E. Pelosin, G. Abbruzzese, L. Avanzino (Genova, Italy)
Defence Mechanism of Ego and Coping Strategy Style of the Patient with Parkinson’s Disease

M. Kulsum, S. Choudhury, A. Ghosh, P. Ghosh (Kolkata, India)
Defining biomarkers to discriminate between organic and functional dystonia

A. Stephan, D. Benninger (Lausanne, Switzerland)
Dementia with Lewy bodies: GBA1 mutations are associated with cerebrospinal fluid alpha-synuclein profile

S. Lerche, G. Machetanz, I. Wurster, B. Roeben, M. Zimmermann, A. Pilotto, A-K. Hauser, C. Schulte, I. Lachmann, T. Gasser, D. Berg, W. Maetzler, K. Brockmann (Tübingn, Germany)
Demographic Influences on Wearing Off Symptoms in Parkinson’s Disease

L. Chahine, G. Cummin, S. Chen, J. Buchanich, B. Edison, M. Daeschler, S. Kahl, C. Kopil, C. Marras (Toronto, ON, Canada)
Dentate nucleus functional connectivity changes and their relationship with motor and non motor symptoms in patients with essential tremor

S. Pietracupa, S. Tikoo, S. Tommasin, M. Bologna, N. Petsas, K. Bharti, G. Grillea, A. Berardelli, P. Pantano (Rome, Italy)
Dentatorubral-Pallidoluysian Atrophy outside of Asia: A case report of the first Austrian family harbouring this rare mutation

M. Amprosi, W. Nachbauer, E. Indelicato, A. Eigentler, G. Puttinger, J. Gusenleitner, T. von Oertzen, S. Boesch (Innsbruck, Austria)
Depression and anxiety in cervical dystonia

M. Munteanu (Bucharest, Romania)
Depression and cognitive impairment in isolated focal-onset dystonia: prevalence and risk factors in a group of Romanian patients

OL. Bajenaru, I. Popescu-Olaru, E. Serban, L. Cozma, F. Raicu, R. Cocos, L. Dumitrescu, BO. Popescu (Bucharest, Romania)
Depression as a risk factor for impulse compulsive disorders in Parkinson’s disease: a prospective survival study

J. Marín-Lahoz, F. Sampedro, S. Martinez-Horta, J. Pagonabarraga, J. Kulisevsky (Barcelona, Spain)
Depression in Parkinson’s diseaese: Experience of the neurology department in Mohammed VI third level university hospital

H. El Yachkouri, M. Chraa, N. Kissani (Marrakesh, Morocco)
Depression, Anxiety and Sleep Disturbances in Patients with Craniocervical Dystonias

Z. Khayatova, Z. Zalyalova (Kazan, Russian Federation)
Depressive Symptoms are Associated with Lower Locus Coeruleus Volumes in Parkinson’s disease

C. Farrell, G. Pagano, E. de Natale, M. Politis (London, United Kingdom)
Describing Dystonia Phenomenology and Preliminary Treatment Response in Migraine Patients

A. Yoo, S. Bobker, S. Broner, A. Lee, G. Auerbach, L. Klebanoff, M. Vo, H. Sarva (New York, NY, USA)
Descriptive Presentation of MRI Findings in Multiple Sclerosis Patients with Tonic Spasm

M. Salari, M. Etemadifar, SH. Ghourchian (Tehran, Islamic Republic of Iran)
Design and Baseline Characteristics of an Open-Label, Randomized, 26-Week Study Comparing Levodopa-Carbidopa Intestinal Gel to Optimized Medical Treatment on Non-Motor Symptoms in Patients with Advanced Parkinson’s Disease – INSIGHTS Study

S. Chung, M. Garriga, M. Ceravolo, N. Tambasco, W. Robieson, M. Facheris, O. Sánchez-Soliño, L. Barbato (Seoul, Republic of Korea)
Design of the PERSPECTIVE study: PERsonalized SPEeCh Therapy for actIVE conversation

J. Maas, N. de Vries, B. Bloem, J. Kalf (Nijmegen, Netherlands)
Design, characterization and In vivo evaluation of intranasal delivery of levodopa loaded microspere for Parkinsonism

S. Jain, A. Jain, SB. Bhargav (Sagar, India)
Detecting unsuspected mitochondrial disease: an algorithmic approach

N. Pulley, C. Condon, I. Haq (Winston-Salem, NC, USA)
Detection of genetic modifiers in PRKN

K. Ogaki, H. Nakaoka, K. Daida, A. Hayashida, A. Ikeda, Y. Li, H. Yoshino, M. Funayama, K. Nishioka, I. Inoue, N. Hattori (Tokyo, Japan)
Detection of impaired finger dexterity by objective keyboard typing test in Parkinson’s Disease: A feasibility study

P. Panyakaew, K. Duangjino, R. Bhidayasiri (Bangkok, Thailand)
Determining Outcome of Deep Brain Stimulation Surgery in Parkinson’s Disease Patients

E. Yoon, S. Ahmed, S. Bandres-Ciga, S. Scholz, C. Lungu, D. Hernandez, A. Singleton, D. Ehrlich (Bethesda, MD, USA)
Developing an innovative telephone support line for people with Parkinson’s Disease

F. Mancini, T. Carta, S. Thomas, F. Bona, E. Buijs, P. Nee, B. Bloem (Milan, Italy)
Development and Validation of the Parkinson’s Disease Medication Adherence Scale (PD- MAS)

M. Tosin, B. Oliveira (Niterói, Brazil)
Development of a patient-reported Botulinum Toxin Response Scale (BTRS) for neurological disorders: a feasibility study.

D. Gupta, C. Gao, S. Pullman (Burlington, VT, USA)
Development of a Predictive Model for Progressive Supranuclear Palsy Using Real World Data

E. Viscidi, Y. Zabar, T. Dam, M. Juneja, J. Kupferman, V. Kupelian, S. Eaton, I. Litvan, G. Hoglinger (Cambridge, MA, USA)
Development of a questionnaire to assess sensory trick in patients with dystonia

L. Avanzino, G. Bonassi, N. Cothros, E. Pelosin, R. Marchese, G. Abbruzzese, F. Morgante, D. Martino (Genova, Italy)
Development of a web-based tool for systematic collection of phenotypes of hereditary movement disorders from medical literature

J. Lee, S. Fujioka, S. Hong, N. Kim, Y. Kim, H. Ma, Y. Tsuboi, Y. Kim (Anyang, Republic of Korea)
Development of an unsupervised analysis pipeline for human microelectrode recordings

SF. Abalde, MD. Mendonça, G. Marques, R. Matias, R. Barbosa, C. Reizinho, A. Seromenho-Santos, P. Pires, P. Bugalho (Lisbon, Portugal)
Development Of Anti-Parkinsonism Poly Herbal Sustained Release Formulation Composed Of Potential Traditional Plant Extracts

S. Jain, A. Jain, S. Bhargav (Sagar, India)
Development of Mucoadhesive Sustained Release Floating Tablets of Silymarin using Natural Polymer for Improved Anti-Parkinson Efficacy

D. Gugulothu, R. Nagapuri, DK. Khatri (Pune, India)
Diagnosing Dementia with Lewy Bodies – Characterizing the prevalence and underlying relationships between core and supportive clinical features

E. Matar, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)
Diagnosis and management strategies used in series of Parkinson’s disease patients who experienced subthalamic nucleus deep brain stimulation induced mood elevation

L. Spiegel, J. Weinstein, J. Ostrem, A. Seritan (San Francisco, CA, USA)
Diagnosis and Treatment Experiences in a Real-World Sample of Tourette Syndrome and Tic Disorder Sufferers

I. Malaty, D. Shineman, W. Deeb (Gainesville, FL, USA)
Diagnostic accuracy of Progressive Supranuclear Palsy: Experience of a movement disorders center

M. Gultekin (Kayseri, Turkey)
Diagnostic journeys of people with Parkinson’s disease in Kenya, sub-Saharan Africa

N. Fothergill Misbah, K. Hampshire, S. Moffatt, J. Kwasa, J. Hooker, R. Walker (Newcastle Upon Tyne, United Kingdom)
Diagnostic potential of automated diffusion imaging for the differential diagnosis of multiple system atrophy and Parkinson’s disease

F. Krismer, V. Beliveau, K. Seppi, G. Goebel, G. Wenning, E. Gizewski, W. Poewe, C. Scherfler (Innsbruck, Austria)
Dielectric Properties of a Blood Plasma Predict Motor Deficits in a 6-Hydroxydopamine-Induced Rat Model of Parkinson’s Disease

E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)
Dietary Vitamin E as a protective factor for Parkinson’s Disease: a clinical and experimental study

T. Schirinzi, G. Martella, P. Imbriani, G. Di Lazzaro, M. Alwardat, M. Pierantozzi, N. Mercuri, A. Pisani (Rome, Italy)
Difference in perception of the wearing-off between patients and physicians in Parkinson’s disease

Y. Tsuboi, R. Nakagawa, M. Ishido, Y. Yoshinaga, T. Hashimoto, T. Mishima, S. Fujioka (Fukuoka, Japan)
Differences in botulinum toxin long-term treated and non-treated cervical dystonia patients in somatosensory task-related functional imaging response.

M. Nevrly, P. Hlustik, P. Hok, M. Kaiserova, P. Otruba, Z. Tudos, P. Kanovsky (Olomouc, Czech Republic)
Differences in correlation with cardiac sympathetic denervation between depression and anhedonia in drug naïve Parkinson disease patients

H. Murakami, T. Shiraishi, T. Umehara, S. Omoto, H. Motegi, R. Nakada, T. Sato, A. Onda, H. Matsuno, T. Komatsu, K. Bono, K. Sakai, H. Mitsumura, Y. Iguchi (Tokyo, Japan)
Differences in resting state fMRI distinguish multiple system atrophy and Parkinson disease

A. Peterson, E. Dayan, N. Browner, D. Drazheva, M. Sklerov (Chapel Hill, NC, USA)
Different clinical entities of Segawa syndrome within a family

J. Sarangerel (Ulaanbaatar, Mongolia)
Different patterns of brain activity during lower limb movements in Parkinson’s disease patients with and without freezing of gait

N. Piramide, E. Sarasso, E. Canu, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi, F. Agosta (Milan, Italy)
Different patterns of cortical and subcortical perfusion changes in essential tremor and tremor-dominant Parkinson’s disease using voxel-based analysis of 3D arterial spin-labeling imaging

L. Jin, J. Wang, C. Wang (Shanghai, China)
Differential diagnosis of Parkinsonian Syndromes – combining clinical and imaging data in a machine-learning approach

T. Meindl, Y. Li, A. Jochim, T. Mantel, A. Hapfelmeier, B. Haslinger (Munich, Germany)
Differential effects of stem cell therapy in adult and middle-aged Parkinsonian mice

A. Nelke, S. García-López, A. Martínez-Serrano, M. Pérez Pereira (Madrid, Spain)
Differential effects of stimulation amplitude and lead laterality of deep brain stimulation of the subthalamic nucleus on speech and Parkinsonian motor symptoms

E. Tripoliti, B. Veggia, M. Hariz, P. Limousin (Reggio Emili, Italy)
Differential enhancement of ERK, PKA and Ca2+ signaling in direct and indirect striatal neurons of Parkinsonian mice

LL. Mariani, S. Longueville, JA. Girault, D. Hervé, N. Gervasi (Paris, France)
Differential Gait Progression in idiopathic Parkinson’s disease with and without freezing of gait

A. Glover, L. Pillai, S. Doerhoff, T. Virmani (Little Rock, AR, USA)
Differential Gene Expression in Parkinson Disease and Chronic Traumatic Encephalopathy

FV. Delos Reyes (Quezon City, Philippines)
Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS) based on Duration of Parkinson’s Disease and Dyskinesia

X. Ren, J. Lin, S. Luo, C. Goetz, G. Stebbins, E. Cubo (Burgos, Spain)
Differential temporal processing across Lewy body disorders and relation to cognitive fluctuations

E. Matar, J. Phillips, K. Ehgoetz Martens, G. Halliday, S. Lewis (Sydney, Australia)
Differential Value of Brain Magnetic Resonance Imaging in MSA-C and SCAs

M. Kim, JK. Mun, JH. Ahn, JS. Kim, J. Youn, JW. Cho (Seoul, Republic of Korea)
Differentiating the substantia nigra pars compacta and ventral tegmental area in early-stage Parkinson’s disease using quantitative susceptibility mapping

P. Macdonald, E. Alushaj, N. Handfield-Jones, A. Khan, A. Owen (London, ON, Canada)
Differentiation of Progressive Supranuclear Paralysis from Multisystem Atrophy and Parkinson’s Disease by Cranial MRI

E. Natera-Villalba, V. Ros-Castelló, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, JL. López Sendón, I. Parées-Moreno, JC. Martínez-Castrillo, A. Alonso-Cánovas (Madrid, Spain)
Digenic inheritance of WARS2 and CHRNA6 mutations in infantile parkinsonism

S. Galosi, S. Martinelli, V. Cordeddu, S. Fucile, C. Limatola, R. Carrozzo, M. Tartaglia, V. Leuzzi (Rome, Italy)
Digital biomarker sensor feature data reflect quality of life judgements (PDQ39) in recently diagnosed Parkinson’s disease patients

F. Lipsmeier, K. Taylor, E. Volkova-Volkmar, H. Staunton, R. Postuma, T. Kilchenmann, D. Wolf, Y. Zhang, WY. Cheng, A. Scotland, J. Schjodt-Eriksen, F. Boess, D. Ness, C. Gossens, A. Post, M. Lindemann (Basel, Switzerland)
Digital monitoring of Huntington’s disease with smartphone and smartwatch wearable technology: The Digital-HD study

R. Tortelli, T. Kilchenmann, F. Rodrigues, L. Byrne, A. Bamdadian, F. Lipsmeier, S. Schobel, M. Lindemann, E. Wild (London, United Kingdom)
Diplopia and visual complaints in non-demented patients with Parkinson disease: a Japanese single center cross-sectional survey

K. Ota, K. Takahashi, K. Seo, H. Kawasaki, K. Ikeda, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Tamura, N. Araki, T. Yamamoto (Saitama-Ken, Japan)
Directional Deep Brain Stimulation Lead Implantation: A Single Center Experience

R. Kochanski, A. Borghei, G. Pal, L. Verhagen Metman, F. Lynn, J. Karl, S. Sani (Chicago, IL, USA)
Directional deep brain stimulation: what’s for?

R. Zangaglia, B. Minafra, F. Bruschi, NG. Pozzi, F. Avantaggiato, C. Pacchetti (Pavia, Italy)
Directional lead local field potentials show distinct spatial resolution

J. Jimenez-Shahed, M. Ozturk, A. Viswanathan, S. Sheth, N. Ince (Houston, TX, USA)
Directional leads in deep brain stimulation – surgical handling and evolving therapy options

C.. Matthies, P.. Fricke, R.. Nickl, P.. Capetian, F.. Steigerwald, J.. Volkmann (Wuerzburg, Germany)
Directional stimulation for Dystonic tremor

I. Aviles-Olmos, M. Alegre, J. Artieda, J. Guridi, M. Rodriguez-Oroz (Pamplona, Spain)
Directional versus omnidirectional Deep Brain Stimulation for Parkinson’s disease: Results of a prospective, blinded, multi‑center, single-arm crossover study

AS. Schnitzler, PM. Mir, MB. Brodsky, LV. Verhagen, SG. Groppa, BC. Cheeran, EK. Karst, FD. Defresne, JV. Vesper (Mainz, Germany)
Discriminative power of different olfactory domains in Parkinson’s disease

YW. Zhao, RC. He, JX. Yang, Y. Zhang, XT. Zhou, XX. Zhou, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)
Disease-in-a-dish: drug discovery using patient-derived stem cells in Hereditary Spastic Paraplegia

Y. Fan, G. Wali, R. Sutharsan, C. Sue, A. Mackay-Sim (Sydney, Australia)
Disrupted Functional Brain Connectome in Parkinson’s Disease Patients with Freezing of Gait

N. Li, L. Wang, X. Suo, J. Li, J. Peng, J. Zhang, R. Peng (Chengdu, China)
Disrupted salience network dynamics in Parkinson´s disease patients with impulse control disorders

I. Navalpotro-Gomez, J. Kim, PM. Paz-Alonso, M. Delgado-Alvarado, A. Quiroga-Varela, H. Jimenez-Urbieta, M. Carreiras, AP. Strafella, MC. Rodriguez-Oroz (San Sebastian, Spain)
Dissecting the genetic complexity of Parkinson’s disease: a Parkin-GBA study

Z. Hanss, I. Boussaad, F. Massart, J. Jarazo, R. Krüger (Belvaux, Luxembourg)
Distinct neuronal correlates underpin impulsive action and impulsive choice in Tourette disorder

C. Atkinson-Clement, A. de Liege, C. Porte, Y. Klein-Koerkamp, B. Beranger, A. Hartmann, Y. Worbe (Paris, France)
Distinct phenotypic expression in a large PKAN cohort in the Dominican Republic

S. Baser, C. Muniz, F. Middleton, R. Ericson, M. Santana Jimenez, C. Bass (Pittsburgh, PA, USA)
Distributed Global Functional Connectivity Networks Predict Responsiveness to L-DOPA and Subthalamic Deep Brain Stimulation

C. Wu, T. Foltynie, P. Limousin, L. Zrinzo, H. Akram (Philadelphia, PA, USA)
Distribution Characteristics of Limbs Discomfort in Restless Legs Syndrome

X. Li, YC. Wu, XY. Zhu (Shanghai, China)
DNAJC13 in Parkinson’s disease; characterization of the p.N855S knock-in mouse model

J. Follett, J. Fox, E. Gustavsson, M. Farrrer (Vancouver, BC, Canada)
Do non-motor fluctuations temporarily match ON/OFF motor condition?

E. Del Prete, E. Schmitt, S. Meoni, V. Fraix, A. Castrioto, P. Pelissier, R. Ceravolo, E. Moro (Grenoble, France)
Does Anticholinergic Burden Affect the Outcomes in Patients Diagnosed with Parkinson’s Disease?

S. Taylor, E. Jones (York, United Kingdom)
Does automated analysis of repeat DaTscan imaging aid diagnosis in suspected Lewy body disorders?

F. Richardson, N. Vennart, P. Bartholomew, C. Mcdonald (Gateshead, United Kingdom)
Does cognitive-motor training improve the balance in Parkinson’s disease? Randomized clinical trial

M. Terra, N. Barboza, I. de Almeida, M. Bueno, S. Smaili (Londrina, Brazil)
Does Deep Brain Stimulation in Parkinson’s Disease Change Disease Progression in the Long Run?

A. Løkkegaard, B. Jespersen, M. Karlsborg, A. Clausen, S. Jensen, B. Thomsen (Copenhagen, Denmark)
Does Gait in Real Life differ between People with Parkinson’s Disease and Healthy Controls?

V. Shah, J. Mcnames, C. Curtze, M. Mancini, P. Carlson-Kuhta, J. Nutt, M. El Gohary, F. Horak (Portland, OR, USA)
Does information from the Personal KinetiGraph™ (PKG) influence neurologists´ treatment decisions?

M. Sundgren, P. Rousu, A. Johansson (Stockholm, Sweden)
Does lesion localisation predict tremor characteristics in patients with focal cerebellar lesion?

A. Kovács, M. Kiss, A. Kamondi (Budapest, Hungary)
Does microelectrode recording increase haemorrhage? A comparative study in a large patient cohort over 20 years

J. Runge, A. Saryyeva, M. Wolf, C. Blahak, C. Schrade, HH. Capelle, TM. Kinfe, H. Bäzner, M. Abdallat, JK. Krauss (Hannover, Germany)
Does Physical Activity impact Resting State Functional Connectivity in Parkinson Disease Patients?

R. Guimarães, A. Vieira, B. Campos, L. Piovesana, P. Azevedo, J. Zuiani, A. D'Abreu, F. Cendes (Campinas, Brazil)
Does REM Sleep Behavior Disorder Change in the Progression of Parkinson’s Disease?

M. Figorilli, A. Marques, M. Meloni, B. Pereira, M. Puligheddu, F. Durif, ML. Fantini (Clermont-Ferrand, France)
Does socio-economic status have impact on quality of life in persons with Parkinson’s disease?

R. Aggarwal, V. Goyal, A. Srivastava, M. Behari (Delhi, India)
Does Team-based Outpatient Palliative Care Improve Patient or Care Partner-Centered Outcomes in Parkinson’s Disease and Related Disorders?

B. Kluger, M. Katz, N. Galifianakis, K. Hall, S. Pantilat, R. Khan, C. Friedman, W. Cernik, J. Long, J. Kutner, S. Sillau, J. Miyasaki (San Francisco, CA, USA)
Does the magnitude of improvement of UPDRS III at the preoperative L-dopa test predict the degree of medication decrease one year after subthalamic nucleus Deep Brain Stimulation?

A. Fredricks, G-M. Hariz, J. Linder, L. Eriksson, L. Forsgren, M. Hariz, P. Blomstedt (Umea, Sweden)
Does the truth lie within the gut? Investigating the gut microbiome in an Australian cohort of Parkinson’s disease patients

J. Kenna, S. Mcgregor, M. Horne, A. Tay, S. Ghosh, F. Mastaglia, A. Jefferson, A. Gorecki, M. Bakeberg, S. Walters, R. Anderton (Perth, Australia)
Does Transcranial Direct Current Simulation Improve Motor Functions in Patients with Parkinson’s disease?

E. Bahbah, M. Morsi, M. Aziz, A. Hassanen, A. Ali, M. Abdelmongy, M. Sinokrot, A. Negida, A. Shalash (Damietta, Egypt)
Domain-specific impact of mood/anxiety disorders on quality of life in idiopathic dystonia

D. Martino, Y. Jasaui, J. Sarna, S. Furtado, S. Patten, T. Pringsheim (Calgary, AB, Canada)
Dopamine agonist withdrawal syndrome in Sardinian patients affected by Parkinson’s disease

P. Paolo, R. Pau, G. Orofino, T. Ercoli, F. Marrosu, G. Defazio (Monserrato, Italy)
Dopamine dysregulation syndrome and levodopa-induced dyskinesias in patients with Parkinson’s disease on the background of deep stimulation of the subthalamic nucleus

S. Omarova, N. Fedorova, A. Tomskiy, A. Gamaleya, E. Bril (Moscow, Russian Federation)
Dopamine receptor variants alter outcomes with levodopa in early-stage Parkinson’s disease

D. Fischer, P. Auinger, J. Goudreau, A. Cole-Strauss, K. Kieburtz, J. Elm, M. Hacker, P. Charles, J. Lipton, B. Pickut, C. Sortwell (Grand Rapids, MI, USA)
Dopamine substitution increases connectivity between premotor and motor areas in Parkinson’s disease – a DCM-Study

P. Loehrer, V. Seeger, I. Weber, C. Oehrn, H. Dafsari, M. Tittgemeyer, L. Timmermann (Marburg, Germany)
Dopaminergic imaging in patients with basal ganglia calcification presenting with parkinsonism

A. Planas-Ballvé, N. Caballol, M. Balagué, E. Peral, L. Cano, X. Cardona, L. Vila, A. ávila (Sant Joan Despí, Spain)
Dopaminergic Neuroregeneration in the Diencephalon of 6-OHDA-Lesioned Adult Zebrafish-Based Parkinson’s Disease Model

Y. Vijayanathan, SM. Lim, MP. Tan, FT. Lim, AB. Abdul Majeed, K. Ramasamy (Kuala Lumpur, Malaysia)
Dorsolateral striatal neuronal activity in a rat model of Parkinson`s disease with levodopa-induced dyskinesias

X. Jin, D. Milakara, K. Schwabe, J. Krauss, M. Alam (Nanjing, China)
Drooling in Parkinson’s Disease: A [123I]FP-CIT SPECT study

V. Suarez Contreras, Y. Tayyabah, S. Caminiti, M. Politis (London, United Kingdom)
Drug Utilization in a Real World Cohort with Progressive Supranuclear Palsy

G. Hoeglinger, D. Oleske, J. Zamudio, R. Diegidio, J. Holman (Munich, Germany)
Drug-induced dystonia

JB. Paredes, V. Hristova, J. Poles, S. Madrona, P. Torre, I. Moreno, S. Argos, A. Canovas, JC. Castrillo, JL. Moreno (Madrid, Spain)
Drug-induced Negative Myoclonus: A Case Report

L. Lerjefors, M. Mainardi, A. Antonini, M. Carecchio (Padova, Italy)
Drug-Induced Parkinsonism May Persist Beyond Two Years After Discontinuation of Dopamine Transmission Blocking Agents

J. Randhawa, R. Mehanna (Houston, TX, USA)
Dry eye in Parkinson’s disease: symptoms, consequences and treatment options

I. Csoti, N. Koleva-Alazeh (Leun, Germany)
Dual-task in Parkinson’s disease: a gait analysis and functional MRI study

E. Sarasso, A. Gardoni, S. Galantucci, A. Tettamanti, MA. Volontè, M. Filippi, F. Agosta (Milan, Italy)
Duloxetine for pain in Parkinsons disease; A single center double blind randomised placebo controlled trial.

S. Azmin, T. Canento, B. Cruse, S. Sung, M. Farrell, A. Evans (Kuala Lumpur, Malaysia)
Duration of rimabotulinumtoxinB action in the treatment of adult sialorrhea

S. Isaacson, M. Lew, F. Pagan, R. Pahwa, D. Chary, T. Clinch (Boca Raton, FL, USA)
Dyadic analysis of the Parkinson’s disease impact on the patient-spouse couple

E. Constant, E. Brugallé, E. Wawrziczny, B. Flinois, K. Dujardin, P. Antoine (Villeneuve D'Ascq, France)
Dynamic causal modelling of cortical activity in task-specific dystonia

JC. Chen, CC. Chen (Taichung, Taiwan)
Dynamic functional connectivity signature of cognitive decline in Parkinson’s disease

E. Fiorenzato, A. Strafella, J. Kim, R. Schifano, L. Weis, A. Antonini, R. Biundo (Venice, Italy)
Dynamics of Device-based Treatments for Parkinson´s Disease in Germany from 2010 – 2017

L. Tönges, D. Bartig, C. Krogias, D. Richter (Bochum, Germany)
Dysautonomia as a predictor of cognitive outcome after deep brain stimulation in Parkinson’s disease

V. Cabreira, P. Castro, J. Freitas, M. Rosas, E. Azevedo (Porto, Portugal)
Dysbiosis of Gut Microbiota in a selected population of Italian Parkinson’s Disease patients

R. Cerroni, D. Pietrucci, M. Conti, V. Unida, A. Farcomeni, M. Pierantozzi, NB. Mercuri, S. Biocca, A. Desideri, A. Stefani (Rome, Italy)
Dyskinesia Rates in Patients with Parkinson’s Disease on CVT-301 (levodopa inhalation powder)

E. Pourcher, A. Corbin, J. Qian, C. Kenney (Quebec City, QC, Canada)
Dysphagia in Adults with Niemann-Pick Disease Type C

C. Lewis, M. Walterfang, A. Vogel (Melbourne, Australia)
Dysregulated long non-coding RNA in Parkinson’s disease contributes to the apoptosis of dopaminergic neuron

Y. Fan, Z. Xue (Wuhan, China)
Dystonia as a main clinical feature of AAMR with a novel GMPPA mutation:A case report

SL. Li, H. Wang, L. Wang, Y. Guo, XH. Wan, HP. Li, JY. Shi (Peking, China)
Dystonic opisthotonus: A clinical clue to neurodegeneration with brain iron accumulation in young adults

S. Mehta, V. Lal (Chandigarh, India)
Dystonic storm with a change of stimulation from constant voltage to constant current

Z. Guduru, T. Yamasaki, J. Guwell, J. Lamm, D. Ginjupally, S. Grupke, C. van Horne (Lexington, KY, USA)
Dystonic tics in patients with Gilles de la Tourette syndrome

N. Szejko, A. Jakubczyk, A. Dunalska, P. Janik (Warsaw, Poland)
Dystonic versus parkinsonian tremor

J. Svantnerova, Z. Kosutzka, M. Minar (Bratislava, Slovakia)